The decision to use semaglutide during breastfeeding should be personalized, taking into account the individual health circumstances of the mother, the potential benefits of the medication, and the potential risks to the infant
The prevalence of diabetes could increase to more than 54.9 million between 2015 to 2030, and deaths attributed to it will increase by 38 percent to more than 385,000 people per year
Many private plans exclude them entirely
If they persist beyond two weeks or severely limit daily function, inform your healthcare provider about dose adjustment options
The Phase 2 NEJM trial showed 24.2% average body weight reduction at 48 weeks in the 12mg group
Any medical doctor, MD, OD, or ND can give you a prescription for this therapy